UNASSIGNED: We conducted a retrospective review of adult patients undergoing esophageal procedures under general anesthesia who were oxygenated using THRIVE at two academic institutions. Demographic, clinical, and anesthesiologic data were collected and analyzed.
UNASSIGNED: 14 cases performed from March 2021 to March 2022 met inclusion criteria. 13/14 (92.9%) of patients were able to maintain oxygenation throughout the entirety of their procedure. The mean apneic time was 17.9 minutes with a maximum of 32 minutes. One patient required \"rescue\" intubation due to failure to maintain oxygenation. Excluding the sole THRIVE failure, the median SpO2 at the conclusion of surgery was 99% (range 94-100%). A linear regression model yielded an increase in EtCO2 of 0.95 mmHg/min or 0.127 kPa/min. SpO2 was negatively associated with both tobacco pack-year smoking history (R2 = 0.343, P = .014) and BMI (R2 = 0.238, P = .038).
UNASSIGNED: THRIVE is a feasible, safe, and efficacious means of apneic oxygenation for patients undergoing esophageal endoscopic surgery under general anesthesia with neuromuscular paralysis, which may be particularly beneficial in patients with airway stenosis, as post-intubation changes can have severe clinical implications for this patient population. Obese patients and tobacco smokers may be at increased risk of oxygen desaturation when using THRIVE.
我们在两个学术机构对在全身麻醉下接受食道手术并使用THRIVE充氧的成年患者进行了回顾性研究。人口统计,临床,收集和分析麻醉数据。
■从2021年3月至2022年3月进行的14例病例符合纳入标准。13/14(92.9%)的患者能够在整个过程中保持氧合。平均呼吸暂停时间为17.9分钟,最长为32分钟。一名患者因无法维持氧合而需要“抢救”插管。排除唯一的THRIVE故障,手术结束时的SpO2中位数为99%(94-100%).线性回归模型产生了0.95mmHg/min或0.127kPa/min的EtCO2增加。SpO2与烟草包装年吸烟史(R2=0.343,P=0.014)和BMI(R2=0.238,P=0.038)呈负相关。
■成功是可行的,安全,全麻食管内镜手术伴神经肌肉麻痹患者的呼吸暂停氧合的有效方法,这对气道狭窄患者可能特别有益,因为插管后的变化可能对该患者人群产生严重的临床意义。肥胖患者和吸烟者使用THRIVE时,氧饱和度降低的风险可能会增加。